Mount Sinai Neurobiologist Selected as a Howard Hughes Medical Institute Investigator

The Howard Hughes Medical Institute (HHMI) has selected Ian Maze, PhD, Associate Professor of Neuroscience, and Pharmacological Sciences, at the Icahn School of Medicine at Mount Sinai, as an HHMI Investigator.

Mount Sinai Researchers Use Wearable Devices to Identify Psychological Effects of Pandemic

Study links changes in heart rate variability with degree of resilience, as part of larger effort to understand and mitigate the effects of COVID-19 on health care workers

Mount Sinai’s Center for Psychedelic Psychotherapy and Trauma Research Receives $5 Million Grant From The Bob & Renee Parsons Foundation

Funds will support cutting-edge MDMA-assisted therapy for PTSD

Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement

Mount Sinai study is first to compare this anticoagulant with the standard of care in large randomized clinical trial

Mount Sinai Receives $2.9 Million to Study First-of-its-kind Brain Implant for Restoring Function in Paralyzed Patients

Department of Rehabilitation and Human Performance will lead Mount Sinai in national clinical trial

Mount Sinai Queens Earns Prestigious Thrombectomy-Capable Stroke Certification From Joint Commission

The hospital achieved this recognition by meeting rigorous standards for performing endovascular thrombectomy and demonstrating continuous compliance with its performance standards.

Mount Sinai Study Identifies Significant Inequalities Among Low-Risk Births, Finds Higher Rates of Unexpected Complications for Black and Hispanic Infants

Hospital quality of care during delivery is a major factor for racial and ethnic disparities among low-risk newborns

First of its kind study using multi-omics approach identifies large list of candidate genes associated with alcohol use disorder

New York, NY (Aug 20, 2021) – Researchers from the Icahn School of Medicine at Mount Sinai have published the first study of its kind in the field of addiction genetics using a multi-omics approach to provide a large list…

Mount Sinai Receives NCI Grant to Study Anal Cancer Screening in High-Risk Women

The Icahn School of Medicine at Mount Sinai has been awarded a grant of more than $4 million by the National Cancer Institute for a large-scale study to evaluate anal cancer screening in high-risk women who have been previously diagnosed with human papillomavirus (HPV) infection.

Mount Sinai Mobile Interventional Stroke Team Travels to Patients, Resulting in Faster Treatment and Better Outcomes

Study finds stroke patients are nearly twice as likely to be functionally independent if treated by a specialized team that travels to them to perform surgical clot removal

Study Shows Visual Evoked Potential Is a Promising Tool for Translational Research Into Phelan-McDermid Syndrome and Autism Spectrum Disorders

Researchers at the Seaver Autism Center for Research and Treatment at Mount Sinai have identified specific transient visual evoked potential waveform abnormalities in individuals with Phelan-McDermid syndrome (PMS), proving the method to be an effective, noninvasive technique to gather objective data from a range of individuals, including those who are profoundly affected.

Mount Sinai’s J Mocco, MD, to Lead the Society of NeuroInterventional Surgery

J Mocco, MD, MS, Senior Vice Chair, Director of the Cerebrovascular Center, and Co-Director of the Neuroendovascular Surgery Fellowship Program in the Department of Neurosurgery at Mount Sinai, has been named president-elect of the Society of NeuroInterventional Surgery (SNIS), a scientific and educational association dedicated to advancing the specialty of neurointerventional surgery, effective July 29, 2021.

The Mount Sinai Hospital’s Department of Geriatrics Remains No. 1 in U.S. News & World Report Specialty Rankings for Second Year

The Mount Sinai Hospital’s Department of Geriatrics was ranked No. 1 in the nation by U.S. News & World Report for the second consecutive year. The Mount Sinai Hospital was also listed on the “Honor Roll” of the nation’s top 20 hospitals for the sixth year in a row.

Mount Sinai scientists discover early signs of frontotemporal dementia in personalized cerebral organoids

Frontotemporal dementias are a group of fatal and debilitating brain disorders for which there are no cures. In an article published July 26 in Cell, Mount Sinai researchers describe how they were able to recreate much of the damage seen in a widely studied form of the disease by growing special types of cerebral organoids in petri dishes.

The Steven & Alexandra Cohen Foundation Grants More than $2.1 Million to Support a Psychedelics Research Study at Mount Sinai

The Center for Psychedelic Psychotherapy and Trauma Research in the Department of Psychiatry at Mount Sinai today announced a $2.1 million charitable contribution by the Steven & Alexandra Cohen Foundation.

Mount Sinai Research Reveals How the Ebola Virus Manages to Evade the Body’s Immune Defenses

Mount Sinai researchers have uncovered the complex cellular mechanisms of Ebola virus, which could help explain its severe toll on humans and identify potential pathways to treatment and prevention. In a study published in mBio, the team reported how a protein of the Ebola virus, VP24, interacts with the double-layered membrane of the cell nucleus (known as the nuclear envelope), leading to significant damage to cells along with virus replication and the propagation of disease.

Mount Sinai Welcomes Robotic Prostate Surgery Pioneer Mani Menon, MD

Robotic prostate surgery pioneer Mani Menon, MD, is joining Mount Sinai and will serve as Chief of Strategy and Innovation in the Department of Urology for the Mount Sinai Health System. He will also serve as a Professor of Urology, Director of Education and Director of the Precision Prostatectomy Program in the Department of Urology at Icahn Mount Sinai and Center of Excellence for Prostate Cancer at The Tisch Cancer Institute.

Mount Sinai Leaders Discuss Equity, the Impact of the Pandemic on Healthcare, and the Unprecedented Era and Increasing Interest of Psychedelics on Treating Mental Health at the 2021 Aspen Ideas Health and Aspen Ideas Festival

Reflections on the pandemic, developing innovative solutions to address inequities in health and medicine, and the use of psychedelic drugs to help treat psychiatric disorders are among the topics presented at Aspen Ideas Health and the Aspen Ideas Festival from June 27-July 1, 2021, in Aspen, Colorado. Presented by the Aspen Institute and sponsored by the Mount Sinai Health System, the festival is a unique forum for the exchange of ideas.

Mount Sinai’s Simulation Teaching and Research Center Earns Four Accreditations From Society for Simulation in Healthcare

Only center in the world with this combination of distinctions

The Mount Sinai Hospital Recognized as No. 4 on Newsweek’s World’s Best Smart Hospital 2021 List

The Mount Sinai Hospital is ranked No. 1 in the New York City metropolitan area and No. 4 globally among the most technologically advanced health care institutions on Newsweek’s list of “The World’s Best Smart Hospitals 2021.”

High Caffeine Consumption may be Associated with Increased Risk of Blinding Eye Disease

Frequent caffeine intake could more than triple risk of glaucoma for those genetically predisposed to higher eye pressure

Mount Sinai identifies the causes of racial disparity in prostate cancer in a multi-institutional study

MEDIA ADVISORY Senior Author:  Ash Tewari, MBBS, MCh, Professor and System Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai and Director of the Center of Excellence for Prostate Cancer…

A Technique for Regulating Emotion May be Effective in Disrupting Compulsive Cocaine Addiction, a Mount Sinai Study Has Found

An emotion regulation strategy known as cognitive reappraisal helped reduce the typically heightened and habitual attention to drug-related cues and contexts in cocaine-addicted individuals, a study by Mount Sinai researchers has found.

Fat Around the Heart Linked to Increased Risk of Heart Failure

EMBARGOED UNTIL MAY 24 2:00PM EST (New York, NY – May 24, 2021) – Having excess pericardial fat—fat around the heart—increases the risk of developing heart failure, especially in women, according to new Mount Sinai research. Women with high amounts…

Mount Sinai Cardiovascular Doctors to Receive Honors During American College of Cardiology 70th Annual Scientific Session

William Whang, MD, Associate Professor of Medicine (Cardiology), and Gilbert Tang, MD, MSc, MBA, Associate Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai, are receiving the 2021 Simon Dack Awards for their exceptional contributions to the Journal of the American College of Cardiology (JACC).

Study Shows Significant Reduction in Triglycerides in Patients at High Risk for Acute Pancreatitis Through Novel Monoclonal Antibody

The investigational drug evinacumab reduced triglycerides in patients with severe hypertriglyceridemia (sHTG) and a history of hospitalizations for acute pancreatitis in a phase 2 global study led by Mount Sinai

Biopreparedness Expert Gustavo Palacios, PhD, to Join Mount Sinai, Strengthening Research Collaborations with Department of Defense

Virologist Gustavo Palacios, PhD, is joining the Icahn School of Medicine at Mount Sinai from the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), where he led the application and development of molecular epidemiology to advance the field of biopreparedness. Dr. Palacios will strengthen existing research collaborations between Icahn Mount Sinai and the United States Army-Department of Defense (DoD), laying a foundation for joint research initiatives to protect national and global public health.

Mount Sinai Department of Surgery Launches Program to Combat Burnout and Manage Stress Among Surgical Faculty, Trainees & Staff

Recognizing that burnout and stress have a negative impact on the personal and professional lives of faculty, staff, and trainees, as well as the quality of care that patients receive, the Mount Sinai Department of Surgery has launched the Stress Intervention Tools (SIT) program to help surgeons work through their emotions, reduce their anxiety, and manage crises.

Oula Announces Hospital Partnership with Mount Sinai West for Deliveries

Oula, a modern maternity center combining the best of obstetrics and midwifery care, today announced its partnership with Mount Sinai West, one of New York’s well-respected hospitals, located on the west side of Manhattan. Through this partnership, Oula patients — who receive prenatal, birth, and postpartum care via the company’s collaborative medical team, Brooklyn clinic, and remote care platform — will now be able to deliver their babies at Mount Sinai. They will receive full access to hospital resources and specialists they may need, all while remaining under the care of Oula’s medical team for non-surgical births.

Mount Sinai Study Finds That Blood Clotting Drug Commonly Used for Orthopedic Surgeries Does Not Increase Complications for High-Risk Patients

Mount Sinai Researchers Find That Tranexamic Acid, a Blood Clotting Drug Commonly Used for Orthopedic Surgeries, Does Not Increase Complications for High-Risk Patients

Genetic Ancestry Versus Race Can Provide Specific, Targeted Insights to Predict and Treat Many Diseases

The complex patterns of genetic ancestry uncovered from genomic data in health care systems can provide valuable insights into both genetic and environmental factors underlying many common and rare diseases, according to a team of Mount Sinai researchers.